4/A//SEC Filing
Turney Patricia A. 4/A
Accession 0001567619-22-014989
CIK 0001787306other
Filed
Aug 3, 8:00 PM ET
Accepted
Aug 4, 8:42 PM ET
Size
7.6 KB
Accession
0001567619-22-014989
Insider Transaction Report
Form 4/AAmended
Turney Patricia A.
Senior VP, Manufacturing
Transactions
- Exercise/Conversion
Common Stock
2022-03-23$6.52/sh+15,331$99,958→ 46,444 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-03-23−15,331→ 144,612 totalExercise: $6.52Exp: 2029-11-20→ Common Stock (15,331 underlying)
Footnotes (2)
- [F1]Includes 24,925 restricted stock units.
- [F2]The option vests as to 1/4 of the total shares on November 14, 2020, and then 1/48 of the total shares vest monthly thereafter, with 100% of the total shares vested and exercisable on November 14, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.
Documents
Issuer
Arcutis Biotherapeutics, Inc.
CIK 0001787306
Entity typeother
Related Parties
1- filerCIK 0001801045
Filing Metadata
- Form type
- 4/A
- Filed
- Aug 3, 8:00 PM ET
- Accepted
- Aug 4, 8:42 PM ET
- Size
- 7.6 KB